Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
The AD8 is a brief eight-question informant-based screening tool designed to detect cognitive impairment in primary care visits, taking just two to three minutes to administer. Rather than testing a patient directly, the AD8 asks a family member or caregiver whether they’ve noticed changes in the person’s memory, problem-solving, or everyday functioning—making it practical for busy primary care offices where time is limited and formal cognitive testing isn’t feasible. For example, a daughter accompanying her 72-year-old father to his annual physical can quickly answer whether she’s noticed him getting lost in familiar places or struggling to manage finances, providing the doctor with valuable insight that might otherwise be missed in a standard office visit.
The AD8 emerged from research at Washington University School of Medicine as a tool to identify mild cognitive impairment and dementia early, when interventions can still make a meaningful difference. Primary care is often where cognitive concerns first surface—not in a neurology office, but during a routine blood pressure check or diabetes follow-up. This makes the AD8 valuable because it bridges the gap between noticing something is “off” and getting a formal diagnosis. A score of 2 or higher suggests cognitive impairment may be present and warrants further evaluation.
Table of Contents
- Why Does AD8 Screening Matter in Primary Care Settings?
- Understanding the AD8 Tool and Its Clinical Limitations
- When Should Primary Care Providers Administer AD8 Screening?
- Implementing AD8 Screening in Your Primary Care Practice
- Common Pitfalls and Advanced Challenges in AD8 Administration
- Using AD8 Results to Guide Next Steps
- The Evolving Role of Cognitive Screening in Primary Care
- Conclusion
Why Does AD8 Screening Matter in Primary Care Settings?
Primary care physicians see patients across a wide spectrum of ages and health conditions, yet many have little dedicated time to assess cognition in depth. The ad8 solves this by relying on someone who knows the patient well—someone who spends time with them at home and can speak to real changes in behavior and abilities. This informant perspective captures things a patient might minimize or not fully recognize themselves. A 65-year-old might not notice they’re repeating the same question four times in a conversation, but their spouse will—and that’s exactly the kind of change the AD8 is designed to catch.
The tool becomes especially important because cognitive impairment often goes undetected in primary care. Research shows that without a structured screening tool, primary care doctors miss cognitive problems in roughly 50% of patients who have them. The consequences of that gap can be serious: missed diagnoses delay access to treatments like Lecanemab or Aduhelm for early Alzheimer’s disease, caregivers don’t get the support they need, and patients remain at higher risk for accidents like medication errors or driving mistakes. The AD8 is simple enough that medical assistants or nurses can administer it before the doctor even enters the room, turning a quick questionnaire into a reliable safety net.
Understanding the AD8 Tool and Its Clinical Limitations
The AD8 consists of eight yes-or-no questions about changes the informant has noticed over the past several years: Has the person had trouble remembering things? Does the person have trouble handling money or paying bills? Do they repeat the same question? And so on through questions about getting lost, behavior changes, difficulty with complex tasks, forgetting important events, and overall confusion. Each “yes” counts as one point, and a score of 2 or higher suggests cognitive impairment. The entire questionnaire can be completed in under five minutes. However, the AD8 has real limitations that clinicians need to understand. First, it’s a screening tool, not a diagnostic test—a score of 2 doesn’t mean someone has dementia, only that further evaluation is warranted.
Second, the tool assumes an informed informant is present and willing to answer honestly, which isn’t always the case. A caregiver might be in denial about cognitive changes, or a patient without a regular companion might have no one to provide that history. Third, the AD8 was developed and validated primarily in research settings and specialty clinics, so its performance can differ in real-world primary care offices with more diverse populations. A study comparing the AD8 to more comprehensive cognitive testing found it can miss mild cognitive impairment cases that don’t yet involve obvious functional decline. Additionally, the tool may overidentify cognitive problems in patients with depression or other conditions affecting attention and memory, leading to unnecessary specialist referrals.
When Should Primary Care Providers Administer AD8 Screening?
The most straightforward answer is: whenever cognitive concern arises or in routine screening of older adults. Current guidelines from the American Academy of Family Physicians suggest considering cognitive screening in adults aged 65 and older, especially those with cognitive complaints, memory concerns raised by family, or risk factors like hypertension, diabetes, or depression. Some practices screen all patients over 75 at annual visits; others screen only when a family member mentions concern. Both approaches have merit, and the choice often depends on practice resources and patient population. A practical example: A 78-year-old woman comes in for management of her hypertension. Her daughter is present at the visit and casually mentions, “Mom’s been a little forgetful lately.” This is the moment the AD8 becomes valuable—the doctor hasn’t seen significant impairment themselves, but the family has noticed change, and a quick screening can clarify whether this represents normal aging, mild cognitive impairment, or something else.
Another scenario involves a patient without a family member present but with self-reported memory concerns. In this case, the doctor might ask if a spouse or adult child could fill out the AD8 at home and bring it to the next visit, or the patient might complete a modified version themselves (though the tool is less validated when the patient rather than an informant answers). Conversely, not every visit requires AD8 screening. Patients with established dementia diagnoses don’t need AD8 screening; they need monitoring and management. Younger patients without cognitive concerns or risk factors are unlikely to benefit from screening. The key is using clinical judgment: screen when there’s a reasonable suspicion of cognitive change or as part of routine health maintenance for older adults.
Implementing AD8 Screening in Your Primary Care Practice
Making AD8 screening work in a busy practice requires a simple workflow. Many practices assign this task to a medical assistant or nurse at the beginning of the visit, before the doctor sees the patient. The questionnaire can be printed or administered on a tablet, taking just minutes to complete. Some electronic health records now include the AD8 as a built-in form, which streamlines documentation and flagging of results. The key is consistency: if screening is going to happen, it should happen for all eligible patients, not just those who spontaneously mention memory problems. Training staff is essential.
A medical assistant should understand what the AD8 is screening for and be able to explain it simply to patients and families: “This is a quick set of questions to see if we should look more closely at memory and thinking.” Some families are relieved to have a structured way to report concerns they’ve had for months. Others may feel the questions are intrusive or worry that a high score means their loved one will be labeled with dementia. Clear communication prevents misunderstanding. The tradeoff is between thoroughness and efficiency. A practice that screens everyone over 65 at every visit will identify more cases of early cognitive impairment but will also spend more time on follow-up testing and specialist referrals. A practice that screens selectively (only when concerns are raised) will identify fewer cases but may reduce unnecessary evaluations. There’s no universally “right” answer—it depends on your patient population, available resources, and practice philosophy.
Common Pitfalls and Advanced Challenges in AD8 Administration
One frequent mistake is giving too much weight to a single AD8 result. A score of 1 or 2 can be borderline, and the quality of the informant matters enormously. A caregiver who sees the patient daily will give more accurate responses than someone who visits once a month. Similarly, a caregiver’s own cognitive decline or depression can color their perception of the patient’s functioning. A daughter struggling with grief after a recent loss might overestimate her parent’s cognitive decline; conversely, a caregiver in denial might minimize real problems. Another challenge involves patients who perform normally on brief in-office cognitive testing (like the Montreal Cognitive Assessment) but score high on the AD8.
This discrepancy isn’t rare and highlights an important distinction: the AD8 captures functional decline over time, while office-based cognitive tests measure current performance. Someone can perform adequately on a single test while genuinely struggling with everyday tasks like managing medications or finances. This mismatch is actually clinically useful information—it suggests possible mild cognitive impairment affecting functional abilities—but it can confuse patients and families who think the “normal” test result means there’s no problem. A warning: the AD8 can miss cognitive impairment in highly educated or verbally skilled patients who compensate well. Someone with a PhD might have legitimate cognitive decline that affects their functioning at home but still perform surprisingly well on brief testing because they can rely on extensive knowledge and verbal facility. The AD8 partially addresses this by asking about functional changes rather than purely cognitive performance, but clinicians should remain alert to this possibility.
Using AD8 Results to Guide Next Steps
When the AD8 score is 0 or 1, reassurance is often appropriate. The patient likely doesn’t have cognitive impairment, though they should continue with standard health maintenance. At annual visits, you might rescreen if new concerns emerge, but no immediate follow-up is needed. When the AD8 score is 2 or higher, further evaluation is warranted.
This typically begins with a more thorough cognitive assessment in the primary care office—the Montreal Cognitive Assessment or Mini-Cog are common choices—and a review of medications, thyroid function, vitamin B12 levels, and other treatable conditions that can impair cognition. A 72-year-old with an AD8 score of 4 and memory complaints might have low B12, hypothyroidism, depression, or early Alzheimer’s disease. The workup clarifies which. If primary care cognitive testing suggests mild cognitive impairment or dementia, specialist referral to neurology, geriatrics, or a memory clinic becomes appropriate for neuropsychological testing and imaging.
The Evolving Role of Cognitive Screening in Primary Care
The landscape of cognitive screening in primary care continues to shift. Recent evidence on early Alzheimer’s detection—including new biomarker-based tests (like phosphorylated tau blood tests) and disease-modifying treatments—has reinvigorated interest in identifying cognitive impairment earlier. Practices that previously saw little value in detecting mild cognitive impairment now recognize that patients identified early have access to treatments and lifestyle interventions that might slow decline.
Digital tools and telemedicine are also changing how AD8 screening happens. Some practices now send the AD8 questionnaire to patients and their family members electronically before the visit, allowing time for a thoughtful response and earlier identification of issues. Wearable devices and home-based cognitive assessment apps may eventually supplement or replace traditional screening, though the AD8’s simplicity and proven validity still make it a cornerstone tool.
Conclusion
The AD8 is a practical, evidence-based screening tool that brings cognitive assessment into the routine of primary care. Administered by a family member or caregiver, it takes only minutes and reliably identifies many cases of cognitive impairment that might otherwise be missed. Its simplicity is both its strength—it fits into busy practices—and a limitation: it requires an informed informant and is only the first step in workup, not a definitive diagnosis.
For primary care practices serious about detecting cognitive decline early and connecting patients to available treatments and support, incorporating the AD8 into routine practice for older adults or those with cognitive concerns is a practical and valuable step. The questions are straightforward, the scoring is simple, and the clinical utility is clear. Whether you screen everyone over 75, only when concerns arise, or somewhere in between, having a structured approach using the AD8 ensures that cognitive changes don’t slip through unnoticed.
